MoneyWorks4Me

Biocon informs about FY13 results

09 Apr 2013 Evaluate

Biocon has informed that a meeting of the Board of Directors of the Company will be held on April 25, 2013, to approve and take on record the audited financial results for the year ended on March 31, 2013.Consider recommendation of payment of dividend, if any, for the year 2012-2013.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1235.60
Cipla 1389.90
Lupin 2076.30
Zydus Lifesciences 1217.00
View more..